Global Urinary Drugs Market Status and Outlook 2018-2025

August 2018 | 131 pages | ID: G1137B64633EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost) , Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Sanofi S.A.
• Astellas Pharma Inc.
• Daiichi Sankyo Company Limited
• Pfizer Inc.
• Bayer AG
• Allergan Plc.
• Otsuka Pharmaceutical Co., Ltd.
• GlaxosmithKline Plc

Market by Type

• Oral
• Injectables

Market by Application

• Hospital
• Clinic
• Home Care

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Urinary Drugs Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Oral
  3.1.2 Injectables
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hospital
  4.1.2 Clinic
  4.1.3 Home Care
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Oral Production by Region
    6.1.1.2 Injectables Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hospital Production by Region
    6.1.2.2 Clinic Production by Region
    6.1.2.3 Home Care Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Oral Demand by Region
    6.2.1.2 Injectables Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hospital Demand by Region
    6.2.2.2 Clinic Demand by Region
    6.2.2.3 Home Care Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Sanofi S.A.
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Astellas Pharma Inc.
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Daiichi Sankyo Company Limited
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Pfizer Inc.
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Bayer AG
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 Allergan Plc.
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Otsuka Pharmaceutical Co., Ltd.
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 GlaxosmithKline Plc
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Urinary Drugs Industry Dynamics & Regulations List
Table Global Urinary Drugs Sales Revenue, Cost and Margin, 2015-2018E
Table Global Urinary Drugs Market Status by Type 2015-2018E, in USD Million
Table Global Urinary Drugs Market Status by Application 2015-2018E, in USD Million
Table Global Urinary Drugs Market Status by Application 2015-2018E, in Volume
Table Global Urinary Drugs Market by Region 2015-2018E, in USD Million
Table Global Urinary Drugs Market Share by Region in 2018, in USD Million
Table Global Urinary Drugs Market by Region 2015-2018E, in Volume
Table Global Urinary Drugs Market Share by Region in 2018, in Volume
Table Oral Production Value by Region 2015-2018E, in USD Million
Table Oral Production Volume by Region 2015-2018E, in Volume
Table Injectables Production Value by Region 2015-2018E, in USD Million
Table Injectables Production Volume by Region 2015-2018E, in Volume
Table Hospital Production Value by Region 2015-2018E, in USD Million
Table Hospital Production Volume by Region 2015-2018E, in Volume
Table Clinic Production Value by Region 2015-2018E, in USD Million
Table Clinic Production Volume by Region 2015-2018E, in Volume
Table Home Care Production Value by Region 2015-2018E, in USD Million
Table Home Care Production Volume by Region 2015-2018E, in Volume
Table Oral Market Size by Region 2015-2018E, in USD Million
Table Oral Market Size by Region 2015-2018E, in Volume
Table Injectables Market Size by Region 2015-2018E, in USD Million
Table Injectables Market Size by Region 2015-2018E, in Volume
Table Hospital Market Size by Region 2015-2018E, in USD Million
Table Hospital Market Size by Region 2015-2018E, in Volume
Table Clinic Market Size by Region 2015-2018E, in USD Million
Table Clinic Market Size by Region 2015-2018E, in Volume
Table Home Care Market Size by Region 2015-2018E, in USD Million
Table Home Care Market Size by Region 2015-2018E, in Volume
Table GlobalUrinary Drugs Forecast by Type 2019F-2025F, in USD Million
Table Urinary Drugs Forecast by Type 2019F-2025F, in Volume
Table Urinary Drugs Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Urinary Drugs Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Urinary Drugs Market Forecast by Region 2019F-2025F, in USD Million
Table Urinary Drugs Market Forecast by Region 2019F-2025F, in Volume
Table Sanofi S.A. Information
Table Urinary Drugs Sales, Cost, Margin of Sanofi S.A.
Table Astellas Pharma Inc. Information
Table Urinary Drugs Sales, Cost, Margin of Astellas Pharma Inc.
Table Daiichi Sankyo Company Limited Information
Table Urinary Drugs Sales, Cost, Margin of Daiichi Sankyo Company Limited
Table Pfizer Inc. Information
Table Urinary Drugs Sales, Cost, Margin of Pfizer Inc.
Table Bayer AG Information
Table Urinary Drugs Sales, Cost, Margin of Bayer AG
Table Allergan Plc. Information
Table Urinary Drugs Sales, Cost, Margin of Allergan Plc.
Table Otsuka Pharmaceutical Co., Ltd. Information
Table Urinary Drugs Sales, Cost, Margin of Otsuka Pharmaceutical Co., Ltd.
Table GlaxosmithKline Plc Information
Table Urinary Drugs Sales, Cost, Margin of GlaxosmithKline Plc
Table Global Urinary Drugs Sales Revenue by Company 2015-2017, in USD Million
Table Global Urinary Drugs Sales Volume by Company 2015-2017, in Volume
Table Global Urinary Drugs Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Urinary Drugs Picture
Figure Urinary Drugs Industry Chain Diagram
Figure Global Urinary Drugs Sales Revenue 2015-2018E, in USD Million
Figure Global Urinary Drugs Sales Volume 2015-2018E, in Volume
Figure Global Urinary Drugs Market Status by Type 2015-2018E, in Volume
Figure North America Urinary Drugs Market Size and Growth 2015-2018E, in USD Million
Figure North America Urinary Drugs Market Size and Growth 2015-2018E, in Volume
Figure Europe Urinary Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Europe Urinary Drugs Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Urinary Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Urinary Drugs Market Size and Growth 2015-2018E, in Volume
Figure South America Urinary Drugs Market Size and Growth 2015-2018E, in USD Million
Figure South America Urinary Drugs Market Size and Growth 2015-2018E, in Volume
Figure Middle East Urinary Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Urinary Drugs Market Size and Growth 2015-2018E, in Volume
Figure Africa Urinary Drugs Market Size and Growth 2015-2018E, in USD Million
Figure Africa Urinary Drugs Market Size and Growth 2015-2018E, in Volume
Figure Global Urinary Drugs Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Urinary Drugs Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Urinary Drugs Sales Price Forecast 2019F-2025F
Figure Global Urinary Drugs Gross Margin Forecast 2019F-2025F
Figure Global Urinary Drugs Sales Revenue by Company in 2018, in USD Million
Figure Global Urinary Drugs Price by Company in 2018
Figure Global Urinary Drugs Gross Margin by Company in 2018